Journal of Diabetes and Its Complications
Volume 15, Issue 6 , Pages 307-313 , November 2001

The impact of metabolic and blood pressure control on incidence and progression of nephropathy: A 10-year study of 385 type 2 diabetic patients

  • Ole Torffvit

      Affiliations

    • Department of Internal Medicine, University Hospital, Lund S-221 85, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-46-222-0702; fax: +46-46-211-0908
    • ,
  • Carl-David Agardh

      Affiliations

    • Department of Endocrinology, University Hospital MAS, Malmö, Sweden

Received 8 March 2001 ,Revised 26 June 2001 ,Accepted 6 July 2001.

References 

  1. Baba T, Murabayashi S, Tomiyama T, Takebe K. Uncontrolled hypertension is associated with a rapid progression of nephropathy in type 2 diabetic patients with proteinuria and preserved renal function. Tohoku Journal of Experimental Medicine. 1990;161:311–318
  2. Ballard DJ, Humphrey LL, Melton LJ, Frohnert PP, Chu C-P, O'Fallon WM, et al. Epidemiology of persistent proteinuria in type II diabetes mellitus. Diabetes. 1988;37:405–412
  3. Gæde P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999;353:617–622
  4. Gall M-A, Hougaard P, Borch-Johnsen K, Parving H-H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin-dependent diabetes mellitus: prospective, observational study. BMJ [British Medical Journal]. 1997;314:783–788
  5. Gall M-A, Nielsen FS, Smidt UM, Parving H-H. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 1993;36:1071–1078
  6. Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36:1051–1056
  7. Humphrey LL, Ballard DJ, Frohnert PP, Chu C-P, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population based study in Rochester, Minnesota. Annals of Internal Medicine. 1989;111:788–796
  8. Jerums G, Allen TJ, Tsalamandris C, Akdeniz A, Sinha A, Gilbert R, et al. Relationship of progressively increasing albuminuria to apoprotein (a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients. Diabetologia. 1993;36:1037–1044
  9. John L, Rao PSSS, Kanagasabapathy AS. Rate of progression of albuminuria in type II diabetes. Diabetes Care. 1994;17:888–890
  10. Klein R, Klein BEK, Moss SE. Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes. 1993;42:381–389
  11. Lee ET, Lee VS, Lu M, Lee JS, Russell D, Yeh J. Incidence of renal failure in NIDDM. The Oklahoma Indian diabetes study. Diabetes. 1994;43:572–579
  12. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. New England Journal of Medicine. 1996;335:1636–1642
  13. Nelson RG, Knowler WC, McCance DR, Sievers ML, Pettitt DJ, Charles MA, et al. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria. Diabetologia. 1993;36:1087–1093
  14. Nielsen S, Schmitz A, Rehling M, Mogensen CE. The clinical course of renal function in NIDDM patients with normo- and microalbuminuria. Journal of Internal Medicine. 1997;241:133–141
  15. Niskanen LK, Parviainen M, Penttilä I, Uusitupa MIJ. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care. 1996;19:486–493
  16. Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients. Archives of Internal Medicine. 1992;152:1225–1229
  17. Schmitz A, Væth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia. 1994;37:1251–1258
  18. Smulders YM, Weijers RNM, Rakic M, Slaats EH, Stehouwer CDA, Silberbusch J. Determinants of progression of microalbuminuria in patients with NIDDM. Diabetes Care. 1997;20:999–1005
  19. Tapia, J., Tencer, J., Alm, P., Willner, J., & Torffvit, O. (2000). Albuminuria, HbA1c and LDL levels are associated with histopathological renal changes in type 2 diabetic patients with micro-macroalbuminuria. Diabetes Research and Clinical Practice 50 (Suppl. 1), P1089, S263.
  20. Torffvit O, Agardh E, Agardh C-D. Albuminuria and associated medical risk factors: a cross-sectional study in 451 type II (non-insulin-dependent) diabetic patients. Part 2. Journal of Diabetes and its Complications. 1991;5:129–134
  21. UK Prospective Diabetes Study . Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  22. UK Prospective Diabetes Study . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ [British Medical Journal]. 1998;317:703–713
  23. Walker WG, Hermann J, Murphy RP, Russell RP. Prospective study of the impact of hypertension upon kidney function in diabetes mellitus. Nephron. 1990;55(Suppl. 1):21–26
  24. Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, et al. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia. 1997;40:405–411

PII: S1056-8727(01)00176-3

Journal of Diabetes and Its Complications
Volume 15, Issue 6 , Pages 307-313 , November 2001

Article Tools

* Image Usage & Resolution